Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Zenas BioPharma Inc.

    NASDAQ: ZBIO · Real-Time Price · USD
    11.15
    1.54 (16.02%)
    At close: Jun 06, 2025, 3:59 PM
    11.29
    1.26%
    After-hours: Jun 06, 2025, 05:57 PM EDT

    Zenas BioPharma Statistics

    Share Statistics

    Zenas BioPharma has 41.83M shares outstanding. The number of shares has increased by null% in one year.

    Shares Outstanding

    n/a
    		 41.83M

    Shares Change (YoY)

    n/a
    		 n/a

    Shares Change (QoQ)

    n/a
    		 n/a

    Owned by Institutions (%)

    n/a
    		 23.85%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 4

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 4.92M, so 11.75% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 4.92M

    Short % of Shares Out

    n/a
    		 11.75%

    Short % of Float

    n/a
    		 17.3%

    Short Ratio (days to cover)

    n/a
    		 33.77

    Valuation Ratios

    The PE ratio is -0.69 and the forward PE ratio is -2.5. Zenas BioPharma's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.69

    Forward PE

    n/a
    		 -2.5

    PS Ratio

    n/a
    		 21.62

    Forward PS

    n/a
    		 1.3

    PB Ratio

    n/a
    		 0.35

    P/FCF Ratio

    n/a
    		 -0.9

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Zenas BioPharma.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 6.21, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 6.21

    Quick Ratio

    n/a
    		 6.21

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 -0.01

    Debt / FCF

    n/a
    		 -0.01

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $38,461.54

    Profits Per Employee

    n/a
    		 $-1,207,600

    Employee Count

    n/a
    		 130

    Asset Turnover

    n/a
    		 0.01

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 429K

    Effective Tax Rate

    n/a
    		 -0.27%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is -3.45, so Zenas BioPharma's price volatility has been lower than the market average.

    Beta

    n/a
    		 -3.45

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 9.4

    200-Day Moving Average

    n/a
    		 n/a

    Relative Strength Index (RSI)

    n/a
    		 47.89

    Average Volume (20 Days)

    n/a
    		 184,771

    Income Statement

    In the last 12 months, Zenas BioPharma had revenue of 5M and earned -156.99M in profits. Earnings per share was -3.76.

    Revenue

    n/a
    		 5M

    Gross Profit

    n/a
    		 5M

    Operating Income

    n/a
    		 -163.89M

    Net Income

    n/a
    		 -156.99M

    EBITDA

    n/a
    		 -163.75M

    EBIT

    n/a
    		 -163.89M

    Earnings Per Share (EPS)

    n/a
    		 -3.76
    Full Income Statement

    Balance Sheet

    The company has 319.74M in cash and 1M in debt, giving a net cash position of 318.74M.

    Cash & Cash Equivalents

    n/a
    		 319.74M

    Total Debt

    n/a
    		 1M

    Net Cash

    n/a
    		 318.74M

    Retained Earnings

    n/a
    		 -387.39M

    Total Assets

    n/a
    		 333.77M

    Working Capital

    n/a
    		 268.68M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -119.67M and capital expenditures -131K, giving a free cash flow of -119.81M.

    Operating Cash Flow

    n/a
    		 -119.67M

    Capital Expenditures

    n/a
    		 -131K

    Free Cash Flow

    n/a
    		 -119.81M

    FCF Per Share

    n/a
    		 -9.08
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -3277.76% and -3139.76%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -3277.76%

    Pretax Margin

    n/a
    		 -3131.18%

    Profit Margin

    n/a
    		 -3139.76%

    EBITDA Margin

    n/a
    		 -3275.02%

    EBIT Margin

    n/a
    		 -3277.76%

    FCF Margin

    n/a
    		 -2396.1%

    Dividends & Yields

    ZBIO does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ZBIO is $32.5, which is 236.8% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $32.5

    Price Target Difference

    n/a
    		 236.8%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 7
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 2.6

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist